Choosing the Right HPV Sampling Kit: LBC Sampling vs. Direct HPV Testing

Effective cervical cancer screening begins with the correct sampling method. Two validated configurations serve distinct clinical purposes: the cervical brush MS-CBE002 with cell transport medium MT-CTM001 for liquid-based cytology (LBC), and the cervical swab MS-VF4503 with HPV transport medium MT-HTM001 for direct HPV DNA testing.

LBC Sampling: MSK-HCB001 (MS-CBE002 + MT-CTM001)

The MS-CBE002 cervical brush is engineered to collect cells from both the ectocervix and endocervix in a single motion, releasing them efficiently into MT-CTM001 preservation medium.

Advantages

· Single sample supports both cytology and HPV co-testing

· Preserves cell morphology for detection of cellular abnormalities and infections

· Enables reflex cytology for HPV-positive triage

· Suitable for symptomatic patients requiring cytological evaluation

Applications

· Routine co-testing for women aged 30 and above

· Follow-up of abnormal results

· Laboratories running LBC platforms

Direct HPV Testing:MSK-HPV002 ( MS-VF4503 + MT-HTM001)

The MS-VF4503 flocked swab features a butterfly safety guard and dual breakpoints, with 95% elution efficiency and no PCR inhibitors. Combined with MT-HTM001, it is optimized for HPV nucleic acid detection.

Advantages

· Supports patient self-collection, improving screening coverage

· Optimized for PCR-based HPV assays

· Streamlined workflow for high-throughput screening

· Ergonomic design enhances comfort and reduces contamination risk

Applications

· HPV primary screening programs

· Self-collection initiatives

· Resource-limited settings

· HPV prevalence and genotyping studies

Key Differences

Selection Guidance

Select MSK-HCB001( MS-CBE002 + MT-CTM001) when co-testing or cytology-based screening is required, symptomatic evaluation is needed, or maximum clinical information is desired from a single sample.

Select MSK-HPV002 ( MS-VF4503 + MT-HTM001 ) when HPV primary screening is the protocol, self-collection is prioritized, or high-throughput testing with simplified logistics is the objective.

Conclusion

Both configurations are essential to comprehensive cervical cancer prevention. The LBC kit supports full cytological evaluation with HPV co-testing flexibility, while the direct HPV kit delivers an efficient, patient-friendly solution for primary screening and self-collection. The optimal choice depends on screening strategy, patient population, and laboratory capability.

For product inquiries and sample requests, please contact our sales team.  Email: sales3@mandelab.com